MDxHealth S.A.
MDXH
Classement en actions
#21613
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Prix de l'action
$3.39
Dernière synchronisation: 2023-12-15
Capitalisation boursière
$96.16M
Changement (1 jour)
-1.73%
Changement (1 an)
0.01%
Pays
BE
Échange MDxHealth S.A. (MDXH)
Catégorie
Healthcare
Historique du prix de l'action pour MDxHealth S.A. (MDXH)
Prix de clôture le plus élevé : $3.30 le 2023-12-01
Prix de clôture le plus bas : $109.85 le 2008-08-01
Prix de clôture le plus bas : $109.85 le 2008-08-01
Historique du prix de l'action de MDxHealth S.A. de 2008 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $675.88 | 19.16% |
US
|
|
| $229.29 | 5.13% |
US
|
|
| $396.75 | 111.01% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.69 | 19.07% |
US
|
